XORTX Therapeutics XRTX
NASDAQ XRTX
$0.97 +0.04 (+4.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Amortization of Deferred Charges (2024)

Updated

Analysis

XORTX Therapeutics (XRTX) Amortization of Deferred Charges (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.75 Bn 1,113.34 Bn 19.71 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn
3 AbbVie 502.77 Bn 475.88 Bn 12.70 Bn
4 Merck 356.48 Bn 310.86 Bn 12.21 Bn
5 Novartis Ag 301.04 Bn 265.03 Bn 11.24 Bn
6 Astrazeneca 264.46 Bn 238.15 Bn 12.86 Bn
7 Amgen 238.99 Bn 194.39 Bn 7.24 Bn
8 Gilead Sciences 194.94 Bn 169.14 Bn 6.22 Bn
9 Pfizer 170.77 Bn 117.42 Bn 10.94 Bn
10 XORTX Therapeutics 871,172.86 -2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 78,526.00
Mar 31, 2024 18,472.00
API Access

XORTX Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=XRTX&period=max&api_key=YOUR_API_KEY